Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Translating the role of PARP inhibitors in triple-negative breast cancer.

Beniey M, Haque T, Hassan S.

Oncoscience. 2019 Jan 31;6(1-2):287-288. doi: 10.18632/oncoscience.474. eCollection 2019 Jan. No abstract available.

2.

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.

Hassan S, Esch A, Liby T, Gray JW, Heiser LM.

Mol Cancer Ther. 2017 Dec;16(12):2892-2901. doi: 10.1158/1535-7163.MCT-17-0170. Epub 2017 Sep 27.

Supplemental Content

Loading ...
Support Center